Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Ivana Ćelap

40262

Ivana

Ćelap

doc. dr. sc.

mag. med. biochem., spec. med. biokemije i lab. medicine

assist. prof.

EuSpLM

-333618

nije evidentirano
Naziv Akcije
Margetić, Sandra; Bronić, Ana; Magdić Turković, Tihana; Tomić, Franciska; Ćelap, Ivana Concentrations of direct oral anticoagulants acting as FXa inhibitors could not be accurately determined in patients treated with therapeutic doses of low molecular heparin as bridging therapy // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 458-459 doi: 10.1016/j.rpth.2023.100939
Margetić, Sandra; Ćelap, Ivana; Obuljen, Jasna; Leniček Krleža, Jasna; Linarić, Irena; Tomić, Franciska; Razum, Marija Peak plasma concentrations of apixaban in children, adolescents and young adults with different dosing regimens applied // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 502-503 doi: 10.1016/j.rpth.2023.101004
Margetić, Sandra; Ćelap, Ivana; Razum, Marija, Tomić, Franciska; Šupraha-Goreta, Sandra Presentation of Four Real-Life Patients with Persistently Low Both Peak and Trough Direct Oral Anticoagulant Levels in Plasma: Potential Effect of Drug-Drug Interactions // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 446-446 doi: 10.1016/j.rpth.2023.100951
Ćelap, Ivana; Margetić, Sandra; Mihić, Roman; Razum, Marija Reporting of DOAC concentration as FXa inhibitory units: a possible solution for smaller laboratories // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 486-486 doi: 10.1016/j.rpth.2023.100979
Ivanko, Iva; Ćelap, Ivana; Margetić, Sandra; Marijančević, Domagoj; Vahtarić, Antonio; Josipović, Josipa; Gaćina, Petar Evaluation of Proinflammatory and Haemostasis Markers after BNT162b2 SARS-CoV-2 Vaccination // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 408-409 doi: 10.1016/j.rpth.2023.100860
Ćelap, Ivana; Ivanko, Iva; Margetić, Sandra; Stojanović, Ivana Combined DOAC and antiplatelet therapy caused menorrhagia in young woman - case report // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 460-461 doi: 10.1016/j.rpth.2023.100942
Grubić Rotkvić, Petra ; Ćelap, Ivana ; Bralić Lang, Valerija ; Jug, Juraj ; Snagić, Andrea ; Huljev Šipoš, Ivana ; Cigrovski Berković, Maja Impact of SGLT2 inhibitors on the mechanisms of myocardial dysfunction in type 2 diabetes: A prospective non-randomized observational study in patients with type 2 diabetes mellitus without overt heart disease // Journal of diabetes and its complications, 37 (2023), 8; 108541, 10. doi: 10.1016/j.jdiacomp.2023.108541
Ćelap, Ivana; Margetić, Sandra; Džudović, Jelena; Razum, Marija Comparison of rivaroxaban concentrations measured by anti-Xa rivaroxaban calibrated assay and LC-MS/MS // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 467-467 doi: 10.1016/j.rpth.2023.100953
Fabijanec, Marija; Hulina Tomašković, Andrea; Rumora, Lada; Somborac Bačura, Anita; Čeri, Andrea; Ćelap, Ivana; Ljubičić, Neven; Baršić, Neven; Ramić, Snježana; Barišić, Karmela Expression of microRNAs isolated from formalin-fixed paraffin-embedded tissue samples and exosomes of patients with colorectal carcinoma or adenoma // FEBS Open Bio, 13, Supplement. 2023. str. 90-90 doi: 10.1002/2211-5463.13646
Ivanko, Iva; Ćelap, Ivana; Margetić, Sandra; Marijančević, Domagoj; Josipović, Josipa; Gaćina, Petar Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination // Thrombosis research, 228 (2023), 8; 137-144. doi: 10.1016/j.thromres.2023.06.008
Naziv Uloga Akcije
NextSeq 550 sekvencer kontakt osoba
nije evidentirano